Call for Abstract
Scientific Program
Euro Global Summit and Medicare Expo on Psychiatry, will be organized around the theme “Global research and therapeutic approaches towards psychiatry”
Euro Psychiatry Summit-2015 is comprised of 14 tracks and 86 sessions designed to offer comprehensive sessions that address current issues in Euro Psychiatry Summit-2015.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Implusiveness in eating disorders
- Track 1-2Bipolar disorder
- Track 1-3Neurocognitive deficits and mood disorders
- Track 1-4Depression and anxiety disorder
- Track 1-5Obsessive compulsive disorder
- Track 1-6Antisocial disorder
- Track 1-7Psychopathy and borderline personality disorders
- Track 1-8Behavioral disorder
- Track 2-1Suicide assessment, prevention and treatment
- Track 2-2Case studies
- Track 2-3Psychoneuroimmunology
- Track 2-4Genetic markers of postpartum depression
- Track 2-5Women mental health
- Track 2-6Geriatric psychiatry and diagnosing mental disorders in the elderly
- Track 3-1Schizophrenia and brain systems
- Track 3-2Visual and auditory hallucinations
- Track 3-3Schizophrenia symptoms and diagnosis
- Track 3-4Genetic and Environment influence in Schizophrenia
- Track 3-5Pathophysiology of Schizophrenia
- Track 3-6Management and therapy
- Track 3-7Genetics of Schizophrenia
- Track 4-1Child abuse
- Track 4-2Family violence and domestic harassment
- Track 4-3Psychological abuse and trauma
- Track 4-4Depression and chronic Pain
- Track 4-5Symptoms and risk factors of PTSD
- Track 5-1Suicide assessment, prevention and treatment
- Track 5-2Case studies
- Track 5-3Psychoneuroimmunology
- Track 5-4Genetic markers of postpartum depression
- Track 5-5Women mental health
- Track 5-6Geriatric psychiatry and diagnosing mental disorders in the elderly
- Track 5-7Sexual disorders and mental health
- Track 5-8Social and cultural Psychiatry
- Track 6-1Alcohol and substance abuse
- Track 6-2Neurotoxicity of drug addiction
- Track 6-3Genetics: Substance use disorders
- Track 6-4Drug misuse
- Track 6-5Internet Addiction
- Track 6-6Rehabilitation through various therapies
- Track 6-7Advanced research of addiction
- Track 6-8Addiction: Clinical and case studies
- Track 7-1Is mental illness a myth?
- Track 7-2Mental illness stigma in mental health professionals
- Track 7-3Innovations in Stigma Research
- Track 7-4Strategies to combat stigma
- Track 7-5Role of media in promoting care
- Track 8-1Induced cognitive function and response
- Track 8-2Psychological aspects of cognitive neuroscience
- Track 8-3Cognitive impairment
- Track 8-4Cognitive-behavioral therapy for anxiety disorder
- Track 8-5Preventing relapse
- Track 9-1Criminological studies
- Track 9-2Behavioral forensic science
- Track 9-3Ethical issues
- Track 9-4Recent developments in forensic psychiatry
- Track 9-5Risk assesment and case studies
- Track 10-1Symptoms and conditions behind Psychiatric emergenciesÂ
- Track 10-2Psychiatric interventions
- Track 10-3Education and training in Psychiatric emergencies
- Track 10-4New trends in Emergency Psychiatry
- Track 11-1Psychological effects on Agieng
- Track 11-2Healthy ageing and sleep
- Track 11-3Depression in elderly
- Track 11-4Geriatric Rehabilitation
- Track 11-5Use of psychotropic drugs in elderly patients
- Track 12-1Electroencephalography and Magneto encephalography
- Track 12-2Computed tomography
- Track 12-3Positron emission tomography
- Track 12-4MRI and Functional MRI studies
- Track 12-5Brain mapping studies
- Track 13-1Enhancing therapy with psychotropic medication
- Track 13-2Psychotropic medication and psychotherapy
- Track 13-3Psychotropic medicines during pregnancy
- Track 13-4Dopamine in antidepressant drugs
- Track 13-5Addiction of psychoactive drugs
- Track 13-6Akt/GSK3 signaling in the action of psychotropic drugs
- Track 13-7Psychoanalysis and family therapy
- Track 14-1Botulinum toxin: an emerging therapeutic towards treatment of depression
- Track 14-2Dialectrical behavior therapy
- Track 14-3Transcranial magnetic stimulation therapy
- Track 14-4Creatine metabolism and psychiatric disorders
- Track 14-5Identification of biomarkers for early diagnosis
- Track 14-6Recent Innovations in Electroconvulsive Therapy
- Track 14-7Implementation of mindfulness-based therapies
- Track 14-8Telepsychiatry